Unexpectedly, the decreased GLCE expression was not associated with any main clinical signs of prostate cancer (Gleason score, TNM classification, PSA level), while exactly the increase in GLCE expression (21% of the prostate tumors) was associated with more aggressive disease. This evidence concerns the gene KLK3 and prostate cancer.